DASA3 Stock Overview
Provides diagnostic and hospital services in Brazil and Argentina. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Diagnósticos da América S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$1.75 |
| 52 Week High | R$10.30 |
| 52 Week Low | R$1.68 |
| Beta | 0.30 |
| 1 Month Change | -23.91% |
| 3 Month Change | -36.36% |
| 1 Year Change | -82.34% |
| 3 Year Change | -94.52% |
| 5 Year Change | -96.98% |
| Change since IPO | -70.83% |
Recent News & Updates
Some Diagnósticos da América S.A. (BVMF:DASA3) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 15
Diagnósticos da América (BVMF:DASA3) Has Some Way To Go To Become A Multi-Bagger
Nov 13Recent updates
Some Diagnósticos da América S.A. (BVMF:DASA3) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 15Diagnósticos da América (BVMF:DASA3) Has Some Way To Go To Become A Multi-Bagger
Nov 13Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Benign Growth For Diagnósticos da América S.A. (BVMF:DASA3) Underpins Stock's 30% Plummet
Jun 24Why Investors Shouldn't Be Surprised By Diagnósticos da América S.A.'s (BVMF:DASA3) 25% Share Price Plunge
May 10Risks To Shareholder Returns Are Elevated At These Prices For Diagnósticos da América S.A. (BVMF:DASA3)
Mar 21Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Feb 04Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Jan 08Insufficient Growth At Diagnósticos da América S.A. (BVMF:DASA3) Hampers Share Price
Dec 18Diagnósticos da América (BVMF:DASA3) Is Reinvesting At Lower Rates Of Return
Sep 20Is Diagnósticos da América (BVMF:DASA3) Using Too Much Debt?
Aug 25Diagnósticos da América S.A. (BVMF:DASA3) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 27Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Apr 17Diagnósticos da América (BVMF:DASA3) Seems To Be Using A Lot Of Debt
Mar 13Returns On Capital At Diagnósticos da América (BVMF:DASA3) Paint A Concerning Picture
Dec 14Does Diagnósticos da América (BVMF:DASA3) Have A Healthy Balance Sheet?
Nov 09Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Aug 19Here's Why Diagnósticos da América (BVMF:DASA3) Has A Meaningful Debt Burden
Jul 15Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
May 06Results: Diagnósticos da América S.A. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Apr 01These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Reasonably Well
Mar 02Diagnósticos da América (BVMF:DASA3) Could Be Struggling To Allocate Capital
Jan 25Diagnósticos da América (BVMF:DASA3) Might Be Having Difficulty Using Its Capital Effectively
Oct 10Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Sep 13There Are Reasons To Feel Uneasy About Diagnósticos da América's (BVMF:DASA3) Returns On Capital
Jun 27Diagnósticos da América (BVMF:DASA3) Has A Somewhat Strained Balance Sheet
May 31We're Watching These Trends At Diagnósticos da América (BVMF:DASA3)
Feb 25Shareholders of Diagnósticos da América (BVMF:DASA3) Must Be Delighted With Their 634% Total Return
Jan 03
These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Extensively
Dec 07Shareholder Returns
| DASA3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -17.8% | -10.6% | -7.2% |
| 1Y | -82.3% | -31.7% | -11.5% |
Return vs Industry: DASA3 underperformed the BR Healthcare industry which returned -31.7% over the past year.
Return vs Market: DASA3 underperformed the BR Market which returned -11.5% over the past year.
Price Volatility
| DASA3 volatility | |
|---|---|
| DASA3 Average Weekly Movement | 7.2% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: DASA3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: DASA3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | n/a | Licio Tavares Cintra | www.dasa3.com.br |
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and Diagnostics – International Operations segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations.
Diagnósticos da América S.A. Fundamentals Summary
| DASA3 fundamental statistics | |
|---|---|
| Market cap | R$1.29b |
| Earnings (TTM) | -R$879.04m |
| Revenue (TTM) | R$14.97b |
0.1x
P/S Ratio-1.5x
P/E RatioIs DASA3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DASA3 income statement (TTM) | |
|---|---|
| Revenue | R$14.97b |
| Cost of Revenue | R$10.99b |
| Gross Profit | R$3.99b |
| Other Expenses | R$4.86b |
| Earnings | -R$879.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.18 |
| Gross Margin | 26.62% |
| Net Profit Margin | -5.87% |
| Debt/Equity Ratio | 135.0% |
How did DASA3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 00:09 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Diagnósticos da América S.A. is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Bertan | BB Banco de Investimento S.A. |
| Flavio Yoshida | BofA Global Research |
| Fred Mendes | BofA Global Research |